Celltrion

Celltrion biosimilar expansions in the United States

2 clusters · 5 sources · last updated 4 days ago

Latest: Celltrion's Avtozma receives FDA approval for pediatric COVID-19

Celltrion has expanded its presence in the United States market through the launch and regulatory approval of multiple biosimilar products. In early October 2026, the company launched Omlyclo, the first omalizumab biosi

South Korean biotechnology industry expansion

2 clusters · 4 sources · last updated 5 days ago

Latest: South Korean biotech firms secure spots in top 10 APAC pharma deals

South Korean pharmaceutical companies are transitioning from technology followers to global leaders through the development of blockbuster drugs and significant international acquisitions. Initial projections indicate t

Celltrion pharmaceutical market expansion

2 clusters · 7 sources · last updated 10 days ago

Latest: Celltrion expands European biosimilar market share through new tenders

Celltrion has initiated efforts to expand its global pharmaceutical footprint through strategic partnerships and market penetration. The company announced its participation in the CPHI exhibition in Milan to seek new dru

Celltrion shareholder return policy implementation

3 clusters · 9 sources · last updated 12 days ago

Latest: Celltrion to purchase 100 billion KRW in additional treasury shares

Celltrion has implemented a mid-to-long-term shareholder return policy aimed at utilizing approximately one-third of its annual consolidated net profit to enhance shareholder value. In late August, the company announced

Biopharmaceutical manufacturing expansion in Songdo

2 clusters · 7 sources · last updated 12 days ago

Latest: Daewoong Pharmaceutical opens advanced biopharmaceutical facility in Songdo

Biopharmaceutical manufacturing capacity is expanding within the Songdo Bio Cluster in South Korea. Celltrion has renewed its European Medicines Agency (EMA) Good Manufacturing Practice (EU-GMP) certification for its d

South Korean biotech startup support initiatives

3 clusters · 7 sources · last updated 20 days ago

Latest: KBIOHealth and KITA partner to support biohealth startups' global expansion

Efforts to support the commercialization of biotechnology and pharmaceutical startups in South Korea have expanded through new strategic partnerships. In late August 2026, the KIMCo Foundation and Biolink Partners signe

Celltrion biosimilar market expansion

4 clusters · 6 sources · last updated 24 days ago

Latest: Celltrion's Remsima reaches number one in Japan's infliximab market

Celltrion continues to expand its global biosimilar market share, particularly in autoimmune and oncology treatments. In the United States, the ustekinumab biosimilar Stekyma reached a 16.2% market share in July, marking

Celltrion infliximab product market expansion

2 clusters · 6 sources · last updated 26 days ago

Latest: Celltrion submits Phase 4 clinical trial plan for Zymfentra in the U.S

Celltrion has reported significant growth for its infliximab subcutaneous formulations, Remsima SC and Zymfentra. In the first half of the year, combined sales for these products reached 456.2 billion won. Remsima SC saw

Gender equality and wage gaps in South Korea

2 clusters · 4 sources · last updated 26 days ago

Latest: South Korean corporate gender diversity index rises as female executive share falls

Recent data indicates a complex landscape regarding gender equality in South Korea’s labor market. In the public sector, the gender pay gap has reached the 10% range for the first time, with women in 355 public instituti

Incheon biotechnology workforce development

2 clusters · 4 sources · last updated 27 days ago

Latest: Songdo Bio-process Training Center begins full operations

Incheon’s biotechnology sector is focusing on specialized workforce development to support its growing industrial ecosystem. An initial survey of 119 local biotech companies revealed a significant demand for advanced tra